BiotechTube
Home/Annexon/Arnon Rosenthal, PhD
AR

Arnon Rosenthal, PhD

Co-Founder

Annexon

Therapeutic Areas

AutoimmuneNeurodegenerativeOphthalmic

Annexon Pipeline

DrugIndicationPhase
ANX005Guillain-Barré Syndrome (GBS)Phase 3
ANX007Geographic Atrophy (GA)Phase 3
ANX009Autoimmune Diseases (e.g., Lupus Nephritis)Phase 1b/2a
ANX1502Complement-Mediated DiseasesPhase 1

Leadership Team at Annexon

DL
Douglas Love, Esq.
President & Chief Executive Officer
TY
Ted Yednock, PhD
EVP & Chief Innovation Officer
JD
Jamie Dananberg, M.D.
EVP & Chief Medical Officer
RA
Rick Artis, PhD
Chief Scientific Officer
JL
Jennifer Lew
EVP & Chief Financial Officer
MO
Michael Overdorf, MBA
EVP & Chief Business Officer
TG
Thomas G. Wiggans
Board Chair
BB
Ben Barres, MD, PhD
Scientific Co-Founder
View full Annexon profile